SHERBURN GROUP PRACTICE
BEECH GROVE, SHERBURN IN ELMET, LEEDS
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 39 | 48 | 81.2% | |
| CKD 4 | 2008 | 100 | 116 | 86.2% | |
| CKD 5 | 2009 | 49 | 59 | 83.1% | |
| CKD 5 | 2010 | 7 | 10 | 70.0% | |
| CKD 5 | 2011 | 8 | 9 | 88.9% | |
| CKD 5 | 2012 | 7 | 7 | 100.0% | |
| CKD 5 | 2013 | 11 | 11 | 100.0% | |
| CKD003 | 2014 | 12 | 12 | 100.0% | |
| CKD003 | 2015 | 14 | 17 | 82.4% | |
| NM84 | 2016 | 12 | 14 | 85.7% | |
| NM84 | 2017 | 11 | 14 | 78.6% | |
| NM84 | 2019 | 11 | 15 | 73.3% | |
| NM84 | 2020 | 9 | 12 | 75.0% | |
| NM84 | 2022 | 10 | 13 | 76.9% | |
| NM84 | 2023 | 8 | 13 | 61.5% |
